Advair HFA Information
What's inside Advair HFA
Advair HFA Active Ingredients: fluticasone propionate, salmeterol (as salmeterol xinafoate), details.| Advair HFA Dosages & Strengths | ||||
|---|---|---|---|---|
| Strength | Format | Route | Strength | Class |
| Advair HFA 45 mcg-21 mcg | aerosol with adapter | inhalation | 1.0 inhalation | OTC |
| Advair HFA 115 mcg-21 mcg | aerosol with adapter | inhalation | 1.0 inhalation | OTC |
| Advair HFA 230 mcg-21 mcg | aerosol with adapter | inhalation | 1.0 inhalation | OTC |
Recent Advair HFA Side Effects
Posted by capthugh 6 days ago
My uncle has COPD and takes Spiriva and Advair. He has had pneumonia since June 08 off and on through Sept. I've been concern...
Posted by shmilla 12 days ago
I started taking Advair 500/50 on September 8, 2008. I am sitting at my desk, unable to quiet my racing mind and I am jittery...
Posted by karebear8697 13 days ago
I am a 47 year old female that has had asthma all of my life. I was wanting to stop taking Advair and looked up this website,...
Advair HFA in the News
Pearl Therapeutics, Inc. Expands Its Senior Management Team With ... - SunHerald.com
... products including Advair(R) Diskus(R) and Serevent(R) Diskus(R) for COPD, Serevent(R) and Flovent(R) pediatric programs, Ventolin(R) HFA dose counter, ...
Thu Dec 20 08:44:59 -0500 2007
GSK Supports Emphasis on Asthma Control and Use of Quick ... - PR Newswire (press release)
Advair Diskus is available by prescription only and is approved for the maintenance treatment of asthma in patients four years of age and older. Advair HFA ...
Wed Aug 29 21:08:11 -0400 2007
Commercial Insight: Asthma & COPD - Combination products still ... - Pharmaceutical Business Review
However, combined sales of the Advair franchise (Advair/Seretide and once-daily Beyond Advair) will dominate the asthma/COPD market over the next ten years. ...
Mon Jul 09 18:16:46 -0400 2007
Advair HFA Chemical Information
fluticasone propionate - The propionate salt form of fluticasone, a synthetic trifluorinated glucocorticoid receptor agonist with antiallergic, antiinflammatory and antipruritic effects. Binding and activation of the glucocorticoid receptor results in the activation of lipocortin that in turn inhibits cytosolic phospholipase A2, which triggers cascade of reactions involved in synthesis of inflammatory mediators, such as prostaglandins and leukotrienes. Secondly, mitogen-activated protein kinase (MAPK) phosphatase 1 is induced, thereby leads to dephosphorylation and inactivation of Jun N-terminal kinase directly inhibiting c-Jun mediated transcription. Finally, transcriptional activity of nuclear factor (NF)-kappa-B is blocked, thereby inhibits the transcription of cyclooxygenase 2, which is essential for prostaglandin production.
salmeterol (as salmeterol xinafoate)
Advair HFA RSS Feed